Search research articles
Contact Us
Filters
Showing results (131-140 of 151) with videos related to
Page
of 16
Sort By:
The Lancet. Oncology
|
December 29, 2009
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos, Sophie Postel-Vinay, L Rhoda Molife, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2012
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer
Paul Nathan, Martin Zweifel, Anwar R Padhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors
Ruth Plummer, Laura Vidal, Melanie Griffin, et al.
Cancer Research
|
September 10, 2009
Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents
Yuval Shaked, Terence Tang, Jill Woloszynek, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial
Marie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Cancer Research
|
April 6, 2007
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Alison Maloney, Paul A Clarke, Soren Naaby-Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2015
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial
Henk van den Berg, Michael Paulussen, Gwénaël Le Teuff, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2008
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors
Josep Tabernero, Federico Rojo, Emiliano Calvo, et al.
Page
of 16
Search research articles
Search
Showing results (131-140 of 151) with videos related to
Sort By:
Page
of 16
The Lancet. Oncology
|
December 29, 2009
Safety, pharmacokinetics, and preliminary activity of the anti-IGF-1R antibody figitumumab (CP-751,871) in patients with sarcoma and Ewing's sarcoma: a phase 1 expansion cohort study
David Olmos, Sophie Postel-Vinay, L Rhoda Molife, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 31, 2012
Phase I trial of combretastatin A4 phosphate (CA4P) in combination with bevacizumab in patients with advanced cancer
Paul Nathan, Martin Zweifel, Anwar R Padhani, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 23, 2009
Phase I study of MG98, an oligonucleotide antisense inhibitor of human DNA methyltransferase 1, given as a 7-day infusion in patients with advanced solid tumors
Ruth Plummer, Laura Vidal, Melanie Griffin, et al.
Cancer Research
|
September 10, 2009
Contribution of granulocyte colony-stimulating factor to the acute mobilization of endothelial precursor cells by vascular disrupting agents
Yuval Shaked, Terence Tang, Jill Woloszynek, et al.
Cancer Research
|
June 25, 2009
Lymphopenia as a prognostic factor for overall survival in advanced carcinomas, sarcomas, and lymphomas
Isabelle Ray-Coquard, Claire Cropet, Martine Van Glabbeke, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
July 2, 2014
Cyclophosphamide compared with ifosfamide in consolidation treatment of standard-risk Ewing sarcoma: results of the randomized noninferiority Euro-EWING99-R1 trial
Marie-Cécile Le Deley, Michael Paulussen, Ian Lewis, et al.
Cancer Research
|
April 6, 2007
Gene and protein expression profiling of human ovarian cancer cells treated with the heat shock protein 90 inhibitor 17-allylamino-17-demethoxygeldanamycin
Alison Maloney, Paul A Clarke, Soren Naaby-Hansen, et al.
European Journal of Cancer (Oxford, England : 1990)
|
August 15, 2015
Impact of gender on efficacy and acute toxicity of alkylating agent -based chemotherapy in Ewing sarcoma: secondary analysis of the Euro-Ewing99-R1 trial
Henk van den Berg, Michael Paulussen, Gwénaël Le Teuff, et al.
Oncotarget
|
October 24, 2018
Surrogate endpoints in advanced sarcoma trials: a meta-analysis
Marion Savina, Saskia Litière, Antoine Italiano, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 12, 2008
Dose- and schedule-dependent inhibition of the mammalian target of rapamycin pathway with everolimus: a phase I tumor pharmacodynamic study in patients with advanced solid tumors
Josep Tabernero, Federico Rojo, Emiliano Calvo, et al.
Page
of 16